Summer Symposium 2015

CANCER COMPLEXITY:
Heterogeneity in Tumor Progression and Drug Response

Friday, June 12, 2015
9 a.m.-4:30 p.m.
Kresge Auditorium, MIT

The 14th annual Koch Institute Summer Symposium, CANCER COMPLEXITY: Heterogeneity in Tumor Progression and Drug Response, will take place on Friday, June 12, 2015, at Kresge Auditorium on the MIT campus in Cambridge, Massachusetts. Registration information will be available in early 2015.

Confirmed Speakers

Michael Hemann, PhD
Symposium Chair
Associate Professor of Biology
Koch Institute at MIT

Christine A. Iacobuzio-Donahue, MD, PhD
Associate Director for Translational Research
David M. Rubenstein Center for Pancreatic Cancer Research
Memorial Sloan Kettering Cancer Center 

Tyler Jacks, PhD
Director
David H. Koch Professor of Biology
Koch Institute at MIT 

Garry Nolan, PhD
Rachford and Carlota Harris Professor
Professor of Microbiology & Immunology
Stanford School of Medicine 

Dana Pe'er, PhD
Associate Professor of Biology and Systems Biology
Columbia University 

Kornelia Polyak, MD, PhD
Professor, Department of Medicine Harvard Medicial School
Department of Medical Oncology, Dana-Farber Cancer Institute 

Alice Shaw, MD, PhD
Associate Professor, Department of Medicine, Harvard Medical School
Thoracic Cancer Program, Massachusetts General Hospital
Clinical Investigator, Koch Institute at MIT 
 

Kimberly Stegmaier, MD
Co-Director, Pediatric Hematologic Maligancy Program, Dana-Farber Cancer Institute & Boston Children's Hospital
Associate Professor of Pediatrics, Harvard Medical School 

Frank Stegmeier, PhD
Director & Cambridge Head of Target Validation, Oncology
Novartis 

Sir Michael Stratton, PhD
Director
Wellcome Trust Sanger Institute 

Charles Swanton, PhD
Professor and Chair, Personalised Cancer Medicine, University College London Cancer Institute
Group Leader, Translational Cancer Therapeutics, London Research Institute, Cancer Research UK